Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud
et al
Ann Rheum Dis
.
2020 Oct;79(10):e134.
doi: 10.1136/annrheumdis-2019-215817.
Epub 2019 Jul 11.
Authors
Antonis Fanouriakis
1
,
George Bertsias
2
3
,
Dimitrios T Boumpas
4
Affiliations
1
Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.
2
Department of Rheumatology, University Hospital of Heraklion, Heraklion, Greece.
3
Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Crete, Greece.
4
Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece boumpasd@uoc.gr.
PMID:
31296499
DOI:
10.1136/annrheumdis-2019-215817
No abstract available
Keywords:
disease activity; systemic lupus erythematosus; treatment.
Publication types
Comment
MeSH terms
Humans
Hydroxychloroquine* / therapeutic use
Lupus Erythematosus, Systemic* / drug therapy
Substances
Hydroxychloroquine